Genetic Technologies Limited (GTG.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -377.06 Thousand AUD | 98.01% |
| 2023 | -7.31 Million AUD | 33.94% |
| 2022 | -11.07 Million AUD | 46.47% |
| 2021 | -20.69 Million AUD | -50.73% |
| 2020 | -13.73 Million AUD | -544.19% |
| 2019 | -2.13 Million AUD | 61.15% |
| 2018 | -5.48 Million AUD | 50.06% |
| 2017 | -10.98 Million AUD | 1.71% |
| 2016 | -11.17 Million AUD | 38.96% |
| 2015 | -18.31 Million AUD | -5472.35% |
| 2014 | -328.7 Thousand AUD | 80.9% |
| 2013 | -1.72 Million AUD | 80.62% |
| 2012 | -8.88 Million AUD | -76.35% |
| 2011 | -5.03 Million AUD | -72.28% |
| 2010 | -2.92 Million AUD | 68.34% |
| 2009 | -9.23 Million AUD | 26.99% |
| 2008 | -12.64 Million AUD | -12.6% |
| 2007 | -11.23 Million AUD | -19.27% |
| 2006 | -9.41 Million AUD | 44.46% |
| 2005 | -16.95 Million AUD | -59.94% |
| 2004 | -10.6 Million AUD | -106.62% |
| 2003 | -5.13 Million AUD | 28.33% |
| 2002 | -7.16 Million AUD | -1260.52% |
| 2001 | -526.29 Thousand AUD | 57.19% |
| 2000 | -1.22 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -377.06 Thousand AUD | 0.0% |
| 2024 Q2 | -3.34 Million AUD | 0.0% |
| 2024 FY | -145.41 Thousand AUD | 98.01% |
| 2023 Q2 | -4.43 Million AUD | 0.0% |
| 2023 FY | -7.31 Million AUD | 33.94% |
| 2023 Q4 | -7.31 Million AUD | 0.0% |
| 2022 Q1 | -13.5 Million AUD | 34.74% |
| 2022 FY | -11.07 Million AUD | 46.47% |
| 2022 Q3 | -11.73 Million AUD | 12.41% |
| 2022 Q4 | -11.07 Million AUD | 5.56% |
| 2022 Q2 | -13.39 Million AUD | 0.84% |
| 2021 Q2 | -16.06 Million AUD | 0.0% |
| 2021 FY | -20.69 Million AUD | -50.73% |
| 2021 Q3 | -20.9 Million AUD | -30.09% |
| 2021 Q4 | -20.69 Million AUD | 0.98% |
| 2020 FY | -13.73 Million AUD | -544.19% |
| 2020 Q2 | -2.91 Million AUD | 0.0% |
| 2020 Q4 | -13.73 Million AUD | 0.0% |
| 2019 FY | -2.13 Million AUD | 61.15% |
| 2019 Q2 | -3.23 Million AUD | 0.0% |
| 2019 Q4 | -2.13 Million AUD | 0.0% |
| 2018 FY | -5.48 Million AUD | 50.06% |
| 2018 Q2 | -7.59 Million AUD | 0.0% |
| 2018 Q4 | -5.48 Million AUD | 0.0% |
| 2017 Q4 | -10.98 Million AUD | 0.0% |
| 2017 FY | -10.98 Million AUD | 1.71% |
| 2017 Q2 | -15 Million AUD | 0.0% |
| 2016 Q2 | -14.51 Million AUD | 0.0% |
| 2016 FY | -11.17 Million AUD | 38.96% |
| 2016 Q4 | -11.17 Million AUD | 0.0% |
| 2015 Q2 | 225.19 Thousand AUD | 0.0% |
| 2015 FY | -18.31 Million AUD | -5472.35% |
| 2015 Q4 | -18.31 Million AUD | 0.0% |
| 2014 Q4 | -328.7 Thousand AUD | 0.0% |
| 2014 Q2 | -2.86 Million AUD | 0.0% |
| 2014 FY | -328.7 Thousand AUD | 80.9% |
| 2013 Q3 | -1.72 Million AUD | 71.02% |
| 2013 FY | -1.72 Million AUD | 80.62% |
| 2013 Q2 | -5.94 Million AUD | 0.0% |
| 2013 Q4 | -1.72 Million AUD | 0.0% |
| 2012 FY | -8.88 Million AUD | -76.35% |
| 2012 Q2 | -12.54 Million AUD | 0.0% |
| 2012 Q4 | -8.88 Million AUD | 0.0% |
| 2011 Q2 | -8.16 Million AUD | 0.0% |
| 2011 FY | -5.03 Million AUD | -72.28% |
| 2011 Q4 | -5.03 Million AUD | 0.0% |
| 2010 FY | -2.92 Million AUD | 68.34% |
| 2010 Q4 | -2.92 Million AUD | 0.0% |
| 2010 Q2 | -5.06 Million AUD | 0.0% |
| 2009 Q2 | -10.28 Million AUD | 0.0% |
| 2009 Q4 | -7.45 Million AUD | 0.0% |
| 2009 FY | -9.23 Million AUD | 26.99% |
| 2008 Q2 | -13.6 Million AUD | 0.0% |
| 2008 Q4 | -12.64 Million AUD | 0.0% |
| 2008 FY | -12.64 Million AUD | -12.6% |
| 2007 Q4 | -11.23 Million AUD | 0.0% |
| 2007 FY | -11.23 Million AUD | -19.27% |
| 2007 Q2 | -8.74 Million AUD | 0.0% |
| 2006 Q2 | -15.71 Million AUD | 0.0% |
| 2006 FY | -9.41 Million AUD | 44.46% |
| 2006 Q4 | -9.41 Million AUD | 0.0% |
| 2005 FY | -16.95 Million AUD | -59.94% |
| 2005 Q4 | -16.95 Million AUD | 0.0% |
| 2005 Q2 | -10.16 Million AUD | 0.0% |
| 2004 FY | -10.6 Million AUD | -106.62% |
| 2003 FY | -5.13 Million AUD | 28.33% |
| 2002 FY | -7.16 Million AUD | -1260.52% |
| 2001 FY | -526.29 Thousand AUD | 57.19% |
| 2000 FY | -1.22 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Australian Clinical Labs Limited | 282.76 Million AUD | 100.133% |
| BCAL Diagnostics Limited | -5.83 Million AUD | 93.534% |
| Genetic Signatures Limited | -35.03 Million AUD | 98.924% |
| Healius Limited | 1.53 Billion AUD | 100.025% |
| Imagion Biosystems Limited | 5.81 Million AUD | 106.488% |
| Integral Diagnostics Limited | 315.35 Million AUD | 100.12% |
| INOVIQ Ltd | -8.69 Million AUD | 95.665% |
| Microba Life Sciences Limited | -20.49 Million AUD | 98.16% |
| Monash IVF Group Limited | 48.23 Million AUD | 100.782% |
| Rhythm Biosciences Limited | -545.67 Thousand AUD | 30.9% |
| Sonic Healthcare Limited | 3.87 Billion AUD | 100.01% |